RSV testing among U.S. adult outpatients remains infrequent, with only 2.73% of LRTI encounters being tested for RSV compared to 15.1% for influenza.
Cohort (n=2,309,842)
RSV testing remains highly underutilized in US adult outpatients with LRTI, COPD, or CHF exacerbations compared to influenza testing, highlighting a gap in clinical practice that may obscure the true burden of RSV.
Absolute Event Rate: 2.73% vs 15.1%
Despite increases over time, RSV testing remains infrequent among U.S. adult outpatients. This is particularly true among adults with COPD or CHF exacerbations, where RSV should be part of the differential diagnosis. Infrequent testing may reflect lack of specific RSV treatment options.
Perez et al. (Thu,) conducted a cohort in Respiratory Syncytial Virus (RSV) infection in adults with Lower Respiratory Tract Disease (LRTD) (n=2,309,842). RSV testing vs. Influenza testing was evaluated on Occurrence of a standard-of-care RSV or influenza test. RSV testing among U.S. adult outpatients remains infrequent, with only 2.73% of LRTI encounters being tested for RSV compared to 15.1% for influenza.